These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23557927)

  • 1. An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity.
    Chai LY; Netea MG; Tai BC; Khin LW; Vonk AG; Teo BW; Schlamm HT; Herbrecht R; Donnelly JP; Troke PF; Kullberg BJ
    J Antimicrob Chemother; 2013 Jul; 68(7):1655-9. PubMed ID: 23557927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are there risk factors for acute renal failure in adult patients using deoxycholate amphotericin B?
    Tuon FF; Koenig F; Jacometto D; Rocha JL
    Rev Iberoam Micol; 2013 Jan; 30(1):21-4. PubMed ID: 22995903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety.
    Hamill RJ; Sobel JD; El-Sadr W; Johnson PC; Graybill JR; Javaly K; Barker DE
    Clin Infect Dis; 2010 Jul; 51(2):225-32. PubMed ID: 20536366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.
    Maharom P; Thamlikitkul V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex.
    Wade RL; Chaudhari P; Natoli JL; Taylor RJ; Nathanson BH; Horn DL
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):361-7. PubMed ID: 23774005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study.
    Lowry CM; Marty FM; Vargas SO; Lee JT; Fiumara K; Deykin A; Baden LR
    Transpl Infect Dis; 2007 Jun; 9(2):121-5. PubMed ID: 17461997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries.
    Ullmann AJ; Sanz MA; Tramarin A; Barnes RA; Wu W; Gerlach BA; Krobot KJ; Gerth WC;
    Clin Infect Dis; 2006 Aug; 43(4):e29-38. PubMed ID: 16838223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis.
    Wingard JR; Kubilis P; Lee L; Yee G; White M; Walshe L; Bowden R; Anaissie E; Hiemenz J; Lister J
    Clin Infect Dis; 1999 Dec; 29(6):1402-7. PubMed ID: 10585786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients.
    Miller CB; Waller EK; Klingemann HG; Dignani MC; Anaissie EJ; Cagnoni PJ; McSweeney P; Fleck PR; Fruchtman SM; McGuirk J; Chao NJ
    Bone Marrow Transplant; 2004 Mar; 33(5):543-8. PubMed ID: 14730342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute renal failure with amphotericin B in lipid emulsion.
    Gales MA; Gales BJ; Alford KM
    Ann Pharmacother; 1996 Sep; 30(9):1036. PubMed ID: 8876871
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk factors of amphotericin B toxicty in the nonneonatal pediatric population.
    Dutta A; Palazzi DL
    Pediatr Infect Dis J; 2012 Sep; 31(9):910-4. PubMed ID: 22581225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria lowers the risk of amphotericin B-associated hypokalaemia.
    Mohan S; Ahmed S; Alimohammadi B; Jaitly M; Cheng JT; Pogue VA
    J Antimicrob Chemother; 2007 Sep; 60(3):690-3. PubMed ID: 17597057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).
    Cornely OA; Maertens J; Bresnik M; Ebrahimi R; Ullmann AJ; Bouza E; Heussel CP; Lortholary O; Rieger C; Boehme A; Aoun M; Horst HA; Thiebaut A; Ruhnke M; Reichert D; Vianelli N; Krause SW; Olavarria E; Herbrecht R;
    Clin Infect Dis; 2007 May; 44(10):1289-97. PubMed ID: 17443465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain.
    Aguado JM; Lumbreras C; González-Vidal D;
    Clin Microbiol Infect; 2004 Sep; 10(9):785-90. PubMed ID: 15355408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should we continue using amphotericin B deoxycholate for the treatment of fungal infections? Adverse events and clinical outcomes.
    Garbino J; Markham L; Matulionyte R; Rives V; Lew D
    Scand J Infect Dis; 2006; 38(2):110-3. PubMed ID: 16449001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dose of the normal saline pre-infusion and other risk factors for amphotericin B deoxycholate-associated acute kidney injury.
    Virojanawat M; Tungsanga S; Paitoonpong L; Katavetin P
    Asian Biomed (Res Rev News); 2023 Dec; 17(6):281-286. PubMed ID: 38161348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].
    Rieger CT; Dittmer M; Ostermann H
    Dtsch Med Wochenschr; 2007 Oct; 132(40):2062-6. PubMed ID: 17899499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.
    Goldstein SL; Leung JC; Silverstein DM
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):979-86. PubMed ID: 17699316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of acute renal failure in patients receiving parenteral amphotericin B.
    Bates DW; Su L; Yu DT; Chertow GM; Seger DL; Gomes DR; Platt R
    Kidney Int; 2001 Oct; 60(4):1452-9. PubMed ID: 11576359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety of long-term administration of conventional amphotericin B in oncology patients].
    Doubek M; Mayer J; Horký D
    Cas Lek Cesk; 2002 Mar; 141(5):156-9. PubMed ID: 11998223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.